Days
Hours
Minutes
Seconds
Register to the Endotoxin & TOC 2022 conference seminar

xCELLigence RTCA Cardio – Cardiomyocyte Contractility

About the Product

This series of devices is aimed at research on muscle cells.

  • The Cardio xCELLigence RTCA device monitors cardiomyocyte activity to assess cardiotoxicity using changes in impedance. The contraction-relaxation cycle of cardiomyocytes elicits clear and rhythmic fluctuations which are monitored by the device at the millisecond level. Changes in intensity and recurrence are examined for seconds or days in order to assess cardiomyocyte contraction and feasibility in the presence of various drugs and treatments.
  • The xCELLigence RTCA ePacer device is used for efficient and easy growth of mature and functional hiPSC cardiomyocytes. The ePacer improves the maturation state of cardiomyocytes in 2-3 weeks using precise electrical pacing conditions over different durations. The simple pulse protocol, using precise and consistent electrical step conditions, improves the functionality of the cardiomyocytes and their response to inotropic compounds.
  • The xCELLigence RTCA CardioECR device combines these two devices

Interested in this product?

Ancillary products to this product

Our Brands

Endotoxin & TOC Conference

21-22 March 2022

Endotoxin & TOC Conference

21-22 March 2022